NSDHL

NAD(P) Dependent Steroid Dehydrogenase-Like Gene in Cholesterol Biosynthesis and Developmental Disorders

Gene Information Card

Symbol NSDHL
Full Name NAD(P) Dependent Steroid Dehydrogenase-Like
Gene Type Protein coding
Chromosomal Location Xq28
NCBI Gene ID 50814 ncbi.nlm.nih.gov/gene/50814
Ensembl ID ENSG00000147383
UniProt ID Q15738
OMIM ID 300275
HGNC ID 13398
Aliases H105E3, SDR31E1, XAP104

Description

NSDHL encodes a 3β-hydroxysteroid dehydrogenase involved in the cholesterol biosynthesis pathway, specifically catalyzing the decarboxylation of 4α-carboxysterols. Mutations in this gene cause CK syndrome (X-linked intellectual disability with seizures) and CHILD syndrome (congenital hemidysplasia with ichthyosiform erythroderma and limb defects). The gene is located on the X chromosome and escapes X-inactivation in some tissues.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
CK syndrome Loss-of-function mutations impair cholesterol synthesis, leading to neuronal dysfunction and intellectual disability ClinVar, OMIM #300831
CHILD syndrome Deficiency in NSDHL disrupts cholesterol biosynthesis, causing asymmetric limb and skin abnormalities ClinVar, OMIM #308050
X-linked intellectual disability NSDHL mutations reduce sterol intermediates, affecting brain development OMIM #300275

Expression Profile

Tissue Expression
Tissue nTPM level
Adipose tissue 12.5 Medium
Brain 8.3 Low
Liver 15.2 Medium
Skin 10.1 Medium
Testis 18.7 High
Cell Line Expression
Cell Line nTPM Notes
HepG2 14.3 Hepatocellular carcinoma cell line
SH-SY5Y 9.8 Neuroblastoma cell line
HaCaT 11.2 Keratinocyte cell line
MCF7 7.5 Breast cancer cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.109G>A (p.Gly37Arg) Missense Rare Loss of enzymatic activity; associated with CK syndrome
c.325C>T (p.Arg109*) Nonsense Rare Premature truncation; CHILD syndrome
c.674A>G (p.Asn225Ser) Missense Rare Reduced protein stability; intellectual disability
Mutation functional classification

Loss of Function (LOF)

Most NSDHL mutations are loss-of-function, reducing or abolishing 3β-hydroxysteroid dehydrogenase activity, leading to accumulation of toxic sterol intermediates and impaired cholesterol synthesis.

Gain of Function (GOF)

No gain-of-function mutations have been reported for NSDHL.

Dominant Negative (DN)

No dominant-negative effects have been described; mutations are typically hemizygous in males or subject to X-inactivation patterns in females.

Gene Ontology (GO)

• 3β-hydroxy-Δ5-steroid dehydrogenase activity (GO:0003854) cholesterol biosynthetic process (GO:0006695)
sterol biosynthetic process (GO:0016126) endoplasmic reticulum (GO:0005783)
cytoplasm (GO:0005737)

Pathways

Cholesterol biosynthesis (KEGG: hsa00100)
Metabolism of steroids (Reactome: R-HSA-8957322)
Terpenoid backbone biosynthesis (KEGG: hsa00900)

Protein Summary

NSDHL is a 373-amino acid protein localized to the endoplasmic reticulum. It functions as a NAD(P)-dependent 3β-hydroxysteroid dehydrogenase, catalyzing the decarboxylation of 4α-carboxysterols (e.g., 4α-carboxy-4β-methyl-5α-cholesta-8,24-dien-3β-ol) during cholesterol biosynthesis. The protein contains a conserved short-chain dehydrogenase/reductase (SDR) domain. Defects in NSDHL lead to accumulation of toxic sterol intermediates, particularly in the brain and skin, explaining the neurological and dermatological phenotypes in associated disorders.

Related Products

Product name Cat.No. Species Gene ID
NSDHL Knockout HEK293 Cell Line EDJ-KQ10817 Human 50814 Details Get a Quote
NSDHL Knockout HCT 116 Cell Line EDJ-KQ37179 Human 50814 Details Get a Quote
NSDHL Knockout A-549 Cell Line EDJ-KQ38470 Human 50814 Details Get a Quote
NSDHL Knockout HeLa Cell Line EDJ-KQ38471 Human 50814 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: